Damon Runyon Researchers

Meet Our Scientists
Adam J. Stevens, PhD

Dr. Stevens aims to discover how engineered immune cells may be applied to the treatment of solid tumors that limit the infiltration of endogenous T cells. Dr. Stevens is using protein engineering to design synthetic receptors that direct T cells to tumor-associated antigens and facilitate penetration into the tumor. Once inside the tumor, the engineered cells should serve as signaling hubs to recruit additional immune cells and kill the cancer cells. 

Project title: "Synthetic adhesion molecules: redirecting cell infiltration and organization"
Institution: University of California, San Francisco
Award Program: Fellow
Sponsor(s) / Mentor(s): Wendell A. Lim, PhD
Cancer Type: Skin
Research Area: Immunotherapy